Supportive treatment and its progress of IgA nephropathy
IgA nephropathy is one of the most common primary glomerular diseases in China.At present,the treatment of IgA nephropathy includes supportive treatment and immunosuppressive treatment.The supportive treatment is the cornerstone of the treatment of the disease.The clinical practice guidelines of Kidney Disease Improving Global Outcomes(KDIGO)suggests that the supportive treatment includes lifestyle modification,blood pressure management,sufficient blockade of renin-angiotensin-aldosterone system(RAAS),as well as assessment and intervention of cardiovascular risk.This article reviews the supportive treatment and its progress of IgA nephropathy.
IgA nephropathySupportive treatmentKDIGO clinical practice guideline for the management of glomerular dis-eases